Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Lauren Harr

Physician Assistant Fort Worth, TX Physician Assistant

NPI 1013393669 CMS profile 10518556

1622 8Th Ave Ste 100, Fort Worth, TX 76104

Open in the dashboard

General payments

$14,275

649 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lauren Harr of Fort Worth, TX is reported in the CMS Open Payments database as having received $14,275 across 649 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,818 118
2024 General $3,001 131
2023 General $3,223 150
2022 General $2,475 118
2021 General $2,757 132

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lauren Harr
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Lauren Harr were reported at $2,818. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Lauren Harr Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,757 $132 $37–$438 $132
2022 $2,475 $155 $48–$522 $149
2023 $3,223 $167 $52–$557 $160
2024 $3,001 $178 $55–$600 $164
2025 $2,818 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,793 87 payments
  2. Genzyme Corporation $1,437 52 payments
  3. Novartis Pharmaceuticals Corporation $1,380 55 payments
  4. Amgen Inc. $1,234 57 payments
  5. Sun Pharmaceutical Industries Inc. $1,164 54 payments
  6. Regeneron Healthcare Solutions, Inc. $1,021 49 payments
  7. UCB, Inc. $675 31 payments
  8. Galderma Laboratories, L.P. $641 31 payments
  9. Arcutis Biotherapeutics, Inc. $627 36 payments
  10. Janssen Biotech, Inc. $550 30 payments
  11. Other $3,753 167 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $14,203 648 payments
  2. Education $72 1 payment
Products named General payments · program years 2021–2025
  1. DUPIXENT Immunology $1,991 68 payments
  2. Otezla $1,120 56 payments
  3. SKYRIZI $927 42 payments
  4. RINVOQ $731 35 payments
  5. COSENTYX Dermatology $673 24 payments
  6. DUPIXENT Inflammation And Immunology $536 30 payments
  7. SOTYKTU $515 17 payments
  8. COSENTYX Immunology $487 24 payments
  9. Bimzelx $484 20 payments
  10. TALTZ $469 23 payments
  11. Other $7,928 411 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

310

Median for Physician Assistant: 241

Drug cost

$10,336

Median for Physician Assistant: $4,110

Branded share of claims

0%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Betamethasone Dipropionate Generic 41 $2,725
Tacrolimus Generic 13 $1,670
Fluorouracil Generic 24 $1,321
Clobetasol Propionate Generic 40 $1,236
Doxycycline Hyclate Generic 44 $923
Triamcinolone Acetonide Generic 65 $910
Spironolactone Generic 24 $578
Ketoconazole Generic 36 $510
Doxycycline Monohydrate Generic 12 $301
Hydrocortisone Generic 11 $163

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$72,006

Of which drugs: $1,977

Medicare patients

531

Average age 74

Services billed

2,000

302 women, 229 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 48%
Diabetes 25%
Ischemic heart disease 22%
Chronic kidney disease 19%
Depression 17%
Atrial fibrillation 15%
COPD 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 26 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DUPIXENT
  • GENZYME CORPORATION $397
  • Regeneron Healthcare Solutions, Inc. $293
$690 — —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $315
$315 — —
COSENTYX
  • Novartis Pharmaceuticals Corporation $248
$248 — —
RINVOQ
  • AbbVie, Inc. $217
$217 — —
Zoryve
  • Arcutis Biotherapeutics, Inc. $198
$198 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 26 with Patron

Records

649 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record